SARAH LATCHFORD: Open Payments
NPI 1124036454 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
| GENZYME CORPORATION | 2 | $42 |
| CSL Behring | 2 | $41 |
| Octapharma USA, Inc. | 1 | $25 |
| Cycle Pharmaceuticals Inc | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| PFIZER INC. | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $18 |
Products named: DUPIXENT, Andembry, PANZYGA, AYVAKIT, Sajazir, TEZSPIRE, XELJANZ, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
